Withdrawn Study Aimed to Uncover Kisspeptin's Role in Insulin Secretion

The hypothalamic-pituitary-gonadal (HPG) axis plays a crucial role in reproductive function, with kisspeptin acting as a key regulator. Emerging evidence suggests a potential link between reproductive hormones and metabolic diseases, including insulin resistance and type 2 diabetes. However, the direct impact of exogenous kisspeptin on human insulin secretion and glucose metabolism has remained largely unexplored.

This Phase 1 study was unfortunately withdrawn before any participants could be enrolled, resulting in no data or findings to report. The primary objective was to quantify how kisspeptin infusion would impact insulin secretion and glucose metabolism during a hyperglycemic clamp. Researchers intended to measure key metabolic parameters like C-peptide levels (a marker of insulin production) and glucose infusion rates (indicating insulin sensitivity). > Had the study proceeded, it would have provided crucial preliminary insights into kisspeptin's direct effects on pancreatic beta-cell function and systemic glucose regulation in humans. The absence of results means the specific impact of kisspeptin on these metabolic processes remains to be elucidated by future research.